Press Releases

Here Evidentic shares press releases of the company with his visitors/clients.

The different immune mechanisms which are engaged to kill tumor cells by using bispecific antibodies as a tumor therapy

News, Press Releases

Bispecific Antibody Therapies in Cancer Immunology – Evidentic Scholarship 2021

Evidentic has launched a scholarship program in order to promote research projects of young researchers. This year we have awarded Ashley Reid, a PhD student from the Icahn School of Medicine at Mount Sinai, New York, United States

Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin

+49 (0) 30 959 99 8831 info@evidentic.com
Linkedin Youtube Facebook Twitter
Open Cookie Preferences
Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

Shipping Information

To deliver aliquots to you before the Christmas break, please place your order one week before the following dates:

  • Last shipment outside EU with FedEx: 28th November 2021
  • Last shipment outside EU with World Courier: 6th December 2021
  • Last shipment in the EU: 13th December 2021

Thank you for your understanding, Your Evidentic team